Aug 22, 2024, 15:06
Elias Karam: The ultimate dilemma of corticosteroids and Immunotherapy
Authors: Rik J. Verheijden, Jolien S. de Groot, Babs O. Fabriek, Miki N. Hew, Anne M. May and Karijn P.M. Suijkerbuijk.
“The ultimate dilemma of corticosteroids and Immunotherapy…
Large analysis of 6 clinical trials.
Take away messages:
- Higher corticosteroid peak dose is associated with worse survival across tumor types, while cumulative dose is not.
- Start with lower corticosteroid dose whenever feasible and try not to peak very high.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43